Sunshine Biopharma (SBFM) Interest & Investment Income (2021 - 2026)

Sunshine Biopharma's (SBFM) quarterly Interest & Investment Income came in at $2.0 in Q2 2021.

Sunshine Biopharma (SBFM) Interest & Investment Income (2021 - 2026) Analysis & Trends

Sunshine Biopharma (SBFM) has 1 years of Interest & Investment Income data on file, last reported at $2.0 in Q2 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Int & Inv Inc (Qtr)
1	Haleon	44.05 Bn	43.08 Bn	-	-
2	Teva Pharmaceutical Industries	43.39 Bn	39.74 Bn	2.15 Bn	-
3	Zoetis	31.86 Bn	30.18 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.78 Bn	22.99 Bn	5.10 Bn	154.39 Mn
5	United Therapeutics	22.25 Bn	19.59 Bn	683.80 Mn	31.50 Mn
6	Viatris	18.74 Bn	17.85 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.58 Bn	15.19 Bn	935.80 Mn	12.40 Mn
8	Elanco Animal Health	11.92 Bn	11.39 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.16 Bn	9.99 Bn	-	-
10	Sunshine Biopharma	1.54 Mn	-12.21 Mn	2.43 Mn	48,816.00

Download Data